Why invest in a stock whose growth outlook that lags behind the market? Investors looking for companies with extraordinary future prospects in terms of profitability and returns should look at the following high-growth stocks. Below I’ve put together a list of great potential investments for you to consider adding to your portfolio if growth is a dimension you would like to firm up.
GBST Holdings Limited (ASX:GBT)
GBST Holdings Limited provides software products for the financial service sector. Established in 1984, and currently run by Robert DeDominicis, the company employs 500 people and with the stock’s market cap sitting at AUD A$150.09M, it comes under the small-cap group.
GBT’s projected future profit growth is a robust 33.18%, with an underlying 13.28% growth from its revenues expected over the upcoming years. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. We see this bottom-line expansion directly benefiting shareholders, with expected positive return on equity of 19.37%. GBT ticks the boxes for robust growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. A potential addition to your portfolio? Take a look at its other fundamentals here.
RedFlow Limited (ASX:RFX)
RedFlow Limited develops, manufactures, and sells zinc-bromide flowing electrolyte battery modules worldwide. Founded in 2005, and headed by CEO Richard Aird, the company employs 37 people and with the stock’s market cap sitting at AUD A$92.95M, it comes under the small-cap stocks category.
RFX’s projected future profit growth is an exceptional triple-digit, with an underlying triple-digit growth from its revenues expected over the upcoming years. It appears that RFX’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. We see this bottom-line expansion directly benefiting shareholders, with expected positive return on equity of 18.71%. RFX’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Want to know more about RFX? Other fundamental factors you should also consider can be found here.
Volpara Health Technologies Limited (ASX:VHT)
Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device software industry. Started in 2009, and run by CEO Ralph Highnam, the company employs 39 people and with the stock’s market cap sitting at AUD A$113.48M, it comes under the small-cap group.